Abstract:Developmental glaucoma, a subset of glaucoma, is associated with trabeculodysgenesis and/or anterior segment dysgenesis. It is one of the major causes of childhood blindness. Understanding its genetic background is important to diagnose, and identify potential therapeutic targets, of this disease. The present study aimed to detect the molecular origin of developmental glaucoma in a Chinese pedigree and its association with glaucomatous phenotypes. A three‑generation pedigree with developmental glaucoma was analyzed in the current study; a thorough ocular examination was performed on the proband and other individuals in the family. Genomic DNA was extracted from the peripheral blood of each individual, and possible disease‑causing genes were screened for mutations using a candidate gene panel. Exons and adjacent regions of the target genes were captured and enriched by probe hybridization. The enriched genes were sequenced on an Illumina high‑throughput sequencer. Variations were verified in other family members using Sanger sequencing. Disease causing mutations were analyzed by comparing the sequences and the structures of wild‑type and mutated cytochrome P450 family 1 subfamily B member 1 (CYP1B1) proteins using PyMOL software. The proband was diagnosed with developmental glaucoma and his parents and other relatives were asymptomatic. Novel compound heterozygous mutations, c.3G>A (p.M1I) and c.1310C>T (p.P437L), in CYP1B1 were detected in the proband, with the former inherited from his father and the latter from his mother. The c.3G>A (p.M1I) change is a novel mutation that disrupts the ATG start codon in exon one of CYP1B1 and therefore interferes with the translation start site. In conclusion, the findings of the present study suggested that the aforementioned compound heterozygous mutations in CYP1B1 may have caused developmental glaucoma in this Chinese family. The c.3G>A mutation in CYP1B1 is a novel mutation, and this study expands the gene mutation spectrum of CYP1B1.

Candidate Gene Analysis Identifies Mutations Incyp1b1andltbp2in Indian Families with Primary Congenital Glaucoma

Overview of Cytochrome P450 1B1 Gene Mutations in Patients with Primary Congenital Glaucoma

Investigation of CYP1B1 mutations in Chinese patients with primary congenital glaucoma.

CYP 1 B 1 and MYOC Mutations in 116 Chinese Patients with Primary Congenital Glaucoma

[A Novel Mutation of CYP1B1 Gene in Primary Congenital Glaucoma].

Bioinformatics Analysis of CYP1B1 Mutation Hotspots in Chinese Primary Congenital Glaucoma Patients.

Screening of the LTBP2 Gene in 214 Chinese Sporadic CYP1B1-negative Patients with Primary Congenital Glaucoma

Screening of Candidate Genes at GLC3B and GLC3C Loci in Chinese Primary Congenital Glaucoma Patients with Targeted Next Generation Sequencing

Exome sequencing identifies novel genes underlying primary congenital glaucoma in the National Birth Defects Prevention Study

Geographical Variability in CYP1B1 Mutations in Primary Congenital Glaucoma

[Two Variants in MYOC and CYP1B1 Genes in a Chinese Family with Primary Angle-Closure Glaucoma].

Mutation Profile of Glaucoma Candidate Genes in Mauritanian Families with Primary Congenital Glaucoma

Novel compound heterozygous mutations in CYP1B1 identified in a Chinese family with developmental glaucoma

GUCY2D Gene Loss-of-Function Mutations Responsible for Leber Congenital Amaurosis 1

Cyp1b1 Genotype Influences the Phenotype in Primary Congenital Glaucoma and Surgical Treatment

A Novel Mutation in PCK2 Gene Causes Primary Angle-Closure Glaucoma

Identification of A Novel Missense Mutation of Mip in A Chinese Family with Congenital Cataracts by Target Region Capture Sequencing

The Pathogenicity of Novel GUCY2D Mutations in Leber Congenital Amaurosis 1 Assessed by HPLC-MS/MS.

Sequence Analysis Of Myoc And Cyp1b1 In A Chinese Pedigree Of Juvenile Glaucoma With Goniodysgenesis

Two Pathogenic Gene Mutations Identified Associating with Congenital Cataract and Iris Coloboma Respectively in a Chinese Family

Mutation spectrum of CYP1B1 in Chinese patients with primary open-angle glaucoma.